Eisenmenger’s syndrome ACC/AHA guidelines for evaluation of patients: Difference between revisions
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
==ACC / AHA 2008 Guidelines- Recommendations for Evaluation of the Patient With Congenital Heart Disease– Pulmonary Arterial Hypertension (DO NOT EDIT) | ==ACC / AHA 2008 Guidelines- Recommendations for Evaluation of the Patient With Congenital Heart Disease– Pulmonary Arterial Hypertension (DO NOT EDIT)<ref name="pmid19038677">{{cite journal| author=Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al.| title=ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=J Am Coll Cardiol | year= 2008 | volume= 52 | issue= 23 | pages= e1-121 | pmid=19038677 | doi=10.1016/j.jacc.2008.10.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19038677 }} </ref>== | ||
<ref name="pmid19038677">{{cite journal| author=Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al.| title=ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=J Am Coll Cardiol | year= 2008 | volume= 52 | issue= 23 | pages= e1-121 | pmid=19038677 | doi=10.1016/j.jacc.2008.10.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19038677 }} </ref> | |||
{| class="wikitable" | {| class="wikitable" | ||
Revision as of 20:06, 22 October 2012
|
Eisenmenger’s syndrome Microchapters |
|
Diagnosis |
|---|
|
Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients |
|
Treatment |
|
Eisenmenger’s syndrome ACC/AHA guidelines for evaluation of patients On the Web |
|
American Roentgen Ray Society Images of Eisenmenger’s syndrome ACC/AHA guidelines for evaluation of patients |
|
FDA on Eisenmenger’s syndrome ACC/AHA guidelines for evaluation of patients |
|
CDC on Eisenmenger’s syndrome ACC/AHA guidelines for evaluation of patients |
|
Eisenmenger’s syndrome ACC/AHA guidelines for evaluation of patients in the news |
|
Blogs on Eisenmenger’s syndrome ACC/AHA guidelines for evaluation of patients |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Priyamavada Singh, MBBS [[2]] Assistant Editor-In-Chief: Kristin Feeney, B.S. [[3]]
Overview
ACC / AHA 2008 Guidelines- Recommendations for Evaluation of the Patient With Congenital Heart Disease– Pulmonary Arterial Hypertension (DO NOT EDIT)[1]
| Class I |
| "1. Care of adult patients with CHD-related PAH should be performed in centers that have shared expertise and training in both ACHD and PAH. (Level of Evidence: C) " |
| "2. The evaluation of all ACHD patients with suspected PAH should include noninvasive assessment of cardiovascular anatomy and potential shunting, as detailed below:
a. Pulse oximetry, with and without administration of supplemental oxygen, as appropriate. (Level of Evidence: C) b. Chest x-ray. (Level of Evidence: C) c. ECG. (Level of Evidence: C) d. Diagnostic cardiovascular imaging via TTE, TEE, MRI, or CT as appropriate. (Level of Evidence: C) e. Complete blood count and nuclear lung scintigraphy. (Level of Evidence: C) " |
| "3. If PAH is identified but its causes are not fully recognized, additional testing should include the following:
a. Pulmonary function tests with volumes and diffusion capacity (diffusing capacity of the lung for carbon monoxide). (Level of Evidence: C) b. Pulmonary embolism–protocol CT with parenchymal lung windows. (Level of Evidence: C) c. Additional testing as appropriate to rule out contributing causes of PAH. (Level of Evidence: C) d. Cardiac catheterization at least once, with potential for vasodilator testing or anatomic intervention, at a center with expertise in catheterization, PAH, and management of CHD-PAH. (Level of Evidence: C) " |
| Class IIa |
| "1. It is reasonable to include a 6-minute walk test or similar nonmaximal cardiopulmonary exercise test as part of the functional assessment of patients with CHD-PAH. (Level of Evidence: C) " |
References
- ↑ Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.